Literature DB >> 12099747

Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.

J Rambeloarisoa1, D Batisse, J-B Thiebaut, J Mikol, S Mrejen, M Karmochkine, M D Kazatchkine, L Weiss, C Piketty.   

Abstract

We report on a case of cryptococcal intramedullary abscess, which occurred three years after a disseminated cryptococcosis and two years after a lymph node cryptococcal recurrence in a HIV-infected patient who exhibited a long-standing immune restoration. At the time of diagnosis, CD4(+) lymphocyte-count was 640x10(6)/l and HIV viral load was undetectable. Spinal involvement is rare during cryptococcosis of the central nervous system. As far as we are aware, there is only one case of proven intramedullary cryptococcal abscess reported in the literature and this case is then the second one. The significant and sustained increase in CD4 count following effective antiretroviral therapy was probably associated with only a partial immune restitution that did not allow to avoid the occurrence of the cryptococcal medullar abscess. Finally, this case raises the question of when to stop secondary prophylaxis of cryptococcal disease after increase in CD4 cell count under antiretroviral therapy. Copyright 2002 The British Infection Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099747     DOI: 10.1053/jinf.2001.0955

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  14 in total

1.  Late onset of cryptococcal cervical lymphadenitis following immune reconstitution inflammatory syndrome in a patient with AIDS.

Authors:  Meenakshi Sethupathi; Kathir Yoganathan
Journal:  BMJ Case Rep       Date:  2015-01-06

2.  Paradoxical cryptococcal immune reconstitution inflammatory syndrome in advanced chronic kidney disease.

Authors:  Chih-Chin Kao; Vin-Cent Wu; Hsin-Yun Sun; Che-Hsiung Wu
Journal:  Int Urol Nephrol       Date:  2012-05-25       Impact factor: 2.370

Review 3.  Cryptococcosis.

Authors:  Eileen K Maziarz; John R Perfect
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

4.  Illness of Immune Reconstitution: Recognition and Management.

Authors:  Edward M Gardner; Elizabeth Connick
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

5.  Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.

Authors:  S Sabbatani; R Manfredi; M Pavoni; A Consales; F Chiodo
Journal:  Mycopathologia       Date:  2004-08       Impact factor: 2.574

6.  Understanding mechanisms underlying the pathology of immune reconstitution inflammatory syndrome (IRIS) by using animal models.

Authors:  Nupur Aggarwal; William Barclay; Mari L Shinohara
Journal:  Curr Clin Microbiol Rep       Date:  2018-06-22

7.  Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.

Authors:  Thomas Kalinoski; Jason Malenfant; Catherine Yim; Arthur Jeng
Journal:  Am J Trop Med Hyg       Date:  2020-04-23       Impact factor: 2.345

Review 8.  Cryptococcal meningitis: a review for emergency clinicians.

Authors:  Kathryn Marie Fisher; Tim Montrief; Mark Ramzy; Alex Koyfman; Brit Long
Journal:  Intern Emerg Med       Date:  2021-01-09       Impact factor: 3.397

9.  Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions.

Authors:  Lewis J Haddow; Robert Colebunders; Graeme Meintjes; Stephen D Lawn; Julian H Elliott; Yukari C Manabe; Paul R Bohjanen; Somnuek Sungkanuparph; Philippa J Easterbrook; Martyn A French; David R Boulware
Journal:  Lancet Infect Dis       Date:  2010-11       Impact factor: 25.071

10.  Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.

Authors:  Caroline Charlier; Françoise Dromer; Christophe Lévêque; Loïc Chartier; Yves-Sébastien Cordoliani; Arnaud Fontanet; Odile Launay; Olivier Lortholary
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.